Emerging Therapies for Atopic Dermatitis: New Drugs and Immunomodulatory Approaches
PDF (Português (Brasil))

Keywords

Atopic dermatitis; Emerging therapies; Immunomodulation.

How to Cite

Maffioletti Ferrari , H., Alencar Pinto Rocha, M. M., de Oliveira Nalini Martins, C., Bellotti Bogéa, T., Almeida Ramos Jaegge, N., Bazani Glória Ferreira , K., Dutra Martinez Emerick , M. G., de Moraes Menezes, K., & Cunha Carrilho, M. E. (2024). Emerging Therapies for Atopic Dermatitis: New Drugs and Immunomodulatory Approaches. Brazilian Journal of Implantology and Health Sciences, 6(3), 1011–1026. https://doi.org/10.36557/2674-8169.2024v6n3p1011-1026

Abstract

In this analysis, different therapeutic interventions for atopic dermatitis are explored, focusing on new drugs and immunomodulatory approaches. Initially, the effectiveness of recently developed pharmacological interventions is highlighted, with an emphasis on their ability to control the symptoms of atopic dermatitis and improve patients' quality of life. Emerging therapies aim to address not only the symptoms but also the underlying causes of the disease, taking into consideration the complex interaction between the immune system and environmental factors.

In addition to pharmacological interventions, innovative approaches such as biological and immunomodulatory therapies are being investigated to modulate the abnormal immune response associated with atopic dermatitis. These new approaches hold significant promise for patients who do not respond adequately to conventional treatments or who experience adverse side effects. Ongoing research in this field is crucial to develop more effective and safer therapies for atopic dermatitis.

Furthermore, it is important to highlight the role of a multidisciplinary approach in the treatment of atopic dermatitis, involving dermatologists, immunologists, allergists, and other healthcare professionals. This collaboration allows for a more comprehensive understanding of the disease and the implementation of more comprehensive and personalized therapeutic strategies for each patient. Finally, it is essential to ensure equitable access to these emerging therapies, especially for individuals with severe or refractory forms of atopic dermatitis, so that all patients can benefit from advances in the field.

In summary, evidence-based therapeutic approaches play a crucial role in the treatment of atopic dermatitis, offering effective options for those affected by the condition. However, it is essential to conduct a careful patient assessment and adopt a personalized approach to ensure the best outcomes and long-term safety of individuals undergoing treatment.

https://doi.org/10.36557/2674-8169.2024v6n3p1011-1026
PDF (Português (Brasil))

References

DAVIS, Dawn M. R. et al. Executive summary: Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies. Journal of the American Academy of Dermatology, v. 90, n. 2, 2023.

DRLJEVIC-NIELSEN, Aska; HEILSKOV, Sofine; DELEURAN, Mette S.; VESTERGAARD, Christian. Immunosuppressive and immunomodulating therapy for atopic dermatitis in pregnancy: an appraisal of the literature. Italian Journal of Dermatology and Venereology, v. 159, n. 1, p. 23-33, 2024.

FERRUCCI, Silvia Mariel; TAVECCHIO, Simona; MARZANO, Angelo Valerio; BUFFON, Stefano. Emerging Systemic Treatments for Atopic Dermatitis. Dermatology and Therapy, v. 13, p. 1071–1081, 2023.

HEINZ, Katja C. et al. Cost‑Effectiveness of Emerging Treatments for Atopic Dermatitis: A Systematic Review. PharmacoEconomics, v. 41, p. 1415–1435, 2023.

KAKKAR, Vandita; SAINI, Komal; SINGH, Kamalinder K. Challenges of current treatment and exploring the future prospects of nanoformulations for treatment of atopic dermatitis. Pharmacological Reports, v. 75, p. 1066–1095, 2023.

KONDRATUK, Katherine; NETRAVALI, Ilka Arun; CASTELO-SOCCIO, Leslie. Modern Interventions for Pediatric Atopic Dermatitis: An Updated Pharmacologic Approach. Dermatology and Therapy, v. 13, p. 367–389, 2023.

KOUMAKI, Dimitra et al. Pruritogenic Mediators and New Antipruritic Drugs in Atopic Dermatitis. Journal of Clinical Medicine, v. 12, p. 2091, 2023.

LYTVYN, Yuliya; GOODERHAM, Melinda. Targeting Interleukin 13 for the Treatment of Atopic Dermatitis. Pharmaceutics, v. 15, p. 568, 2023.

MEYERSBURG, Damian et al. Single-use IgE-selective immunoadsorber column for the treatment of severe atopic dermatitis. Journal of Clinical Apheresis, v. 35, p. 50–58, 2020.

MÜLLER, Svenja et al. Treatment of atopic dermatitis: Recently approved drugs and advanced clinical development programs. Allergy, v. 00, p. 1–15, 2024.

NAHM, Dong-Ho. Regulatory T Cell-Targeted Immunomodulatory Therapy for Long-Term Clinical Improvement of Atopic Dermatitis: Hypotheses and Perspectives. Life, v. 13, p. 1674, 2023.

TENG, Yan et al. Current and Emerging Therapies for Atopic Dermatitis in the Elderly. Clinical Interventions in Aging, v. 18, n. 1641–1652, 2023.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2024 Heloisa Maffioletti Ferrari , Marina Maria Alencar Pinto Rocha, Clara de Oliveira Nalini Martins, Thalita Bellotti Bogéa, Nicole Almeida Ramos Jaegge, Kassia Bazani Glória Ferreira , Maria Gabrielle Dutra Martinez Emerick , Kainã de Moraes Menezes, Maria Eduarda Cunha Carrilho